Accendra Health, Inc. Financial Ratios — ACH Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	15.96	14.23	13.83	8.09	12.46	13.13	8.98	-76.74	-21.19	10.35	51.99	4.07	-7.62	-103.13	- -
Return on Assets (%)	6.11	5.24	4.89	2.63	3.75	3.96	2.39	-12.22	-1.68	0.86	6.45	0.5	-0.79	-7.44	-30.97
Return on Capital (%)	13.23	11.92	11.68	6.2	8.48	9.08	- -	- -	- -	5.84	16.95	- -	0.88	- -	- -
Return on Invested Capital (%)	11.53	10.29	10.17	7.37	8.61	9.25	- -	- -	- -	10.03	18.5	- -	3.65	- -	- -
Gross Margin (%)	9.94	10.43	12.31	12.39	12.43	12.21	12.58	11.37	12.25	15.1	15.46	18.35	47.68	47.77	46.68
EBITDA Margin (%)	2.91	2.78	2.88	2.82	3.02	2.88	2.25	2.36	2.39	3.95	5.45	5.08	16.68	14.15	15.8
Operating Margin (%)	2.51	2.33	2.32	2.14	2.34	2.31	1.61	1.28	1.12	2.85	4.52	2.78	8.44	7.39	8.03
Incremental Operating Margin (%)	-0.12	-4.06	1.78	-2.22	7.94	9.07	18.34	-29.28	8.44	-18.98	15.36	-97.3	0.83	-13.59	28.93
Pretax Margin (%)	2.2	2.07	2.04	1.34	1.77	1.77	0.62	-4.53	-0.31	1.3	2.83	0.11	0.6	-12.31	-3.69
Profit Margin (%)	1.34	1.23	1.22	0.7	1.06	1.12	0.78	-4.64	-0.68	0.35	2.26	0.22	-1.62	-13.53	-39.85
Net Income to Common Margin (%)	1.34	1.23	1.22	0.7	1.05	1.11	0.78	-4.64	-0.68	0.35	2.26	0.22	-1.62	-13.53	-39.85
Effective Tax Rate (%)	39.32	40.55	40.06	47.42	40.3	36.95	- -	- -	- -	19.87	19.93	- -	41.66	- -	- -
Dvd Payout Ratio (%)	44.19	51.08	54.77	94.84	61.21	57.82	86.75	-12.21	-23.14	0.74	0.33	- -	- -	- -	- -
Sustainable Growth Rate (%)	8.91	6.96	6.26	0.42	4.84	5.54	1.19	-86.12	-26.09	10.27	51.82	4.07	-7.62	-103.13	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	213	215	213	609	568	565	901	1,648	1,625	1,106	1,110	2,716	2,320	1,931	2,120
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18	207	43	250
LT Debt	213	215	213	609	568	565	901	1,648	1,625	1,106	1,110	2,698	2,113	1,888	1,870
Total Debt/EBITDA	0.85	0.87	0.81	2.29	1.93	2.02	4.3	7.4	7.39	3.3	2.08	5.37	5.45	5.09	4.86
Net Debt/EBITDA	0.31	0.48	0.42	2.08	1.38	1.36	3.8	7.1	6.56	2.69	1.67	4.81	4.36	4.78	4.05
Total Debt/EBIT	0.98	1.04	1.01	3.01	2.49	2.52	6.01	13.65	15.75	4.57	2.51	9.81	10.77	9.75	9.56
Net Debt/EBIT	0.35	0.57	0.53	2.73	1.78	1.69	5.31	13.1	13.97	3.73	2.02	8.78	8.61	9.16	7.97
EBITDA to Interest Expense	18.33	18.4	19.94	14.63	10.86	10.34	6.59	3.14	2.24	4.02	11.08	3.92	3.65	3.53	4.07
EBITDA-CapEx/Interest Expense	15.68	15.49	15.34	10.73	9.51	9.22	4.99	2.21	1.71	3.31	10.05	2.63	2.12	1.83	2.19
EBIT to Interest Expense	15.84	15.45	16.07	11.14	8.43	8.29	4.72	1.7	1.05	2.9	9.2	2.15	1.84	1.84	2.07
Interest Expense	14	13	13	18	27	27	32	71	98	83	48	129	117	108	107
Common Equity/Total Assets	38.35	35.47	35.19	29.68	30.01	29.71	24.1	8.62	7.23	9.41	15.23	10.44	10.24	3.9	-37.81
Long-Term Debt/Equity (%)	23.14	22.12	20.76	61.42	57.27	58.81	88.7	317.87	351.72	155.32	118.25	285.37	228.64	321.96	- -
Long-Term Debt/Capital (%)	22.15	21.49	20.63	42.84	40.58	41.15	52.54	83.52	86.05	77.89	67.33	82.3	74.36	89.38	156.74
Long-Term Debt/Total Assets (%)	10.92	9.73	9.16	22.25	20.5	20.77	26.68	43.67	44.62	33.16	31.38	50.1	41.49	40.55	76.28
Total Debt/Equity (%)	23.14	22.12	20.76	61.42	57.27	58.81	88.7	317.87	351.72	155.32	118.25	287.26	251.03	329.27	-459.93
Total Debt/Capital (%)	22.15	21.49	20.63	42.84	40.58	41.15	52.54	83.52	86.05	77.89	67.33	82.84	81.64	91.4	177.69
Total Debt/Total Assets (%)	10.92	9.73	9.16	22.25	20.5	20.77	26.68	43.67	44.62	33.16	31.38	50.43	45.55	41.47	86.48
Net Debt to Equity	8.35	12.07	10.82	55.69	41.05	39.49	78.41	305.08	311.88	126.81	95.03	257.13	200.66	309.31	-383.51
Net Debt/Capital (%)	9.31	12.99	11.93	40.46	32.86	31.95	49.46	82.94	79.11	67.54	56	75.76	71.36	87	194.01
EBITDA	251	247	261	266	295	280	209	223	220	335	533	505	426	379	436
EBITDA-CapEx	215	208	201	195	258	250	159	157	168	276	483	339	247	197	235
Operating Income (Loss)	217	207	211	202	229	224	150	121	103	242	442	277	215	198	222

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.19	0.11	0.1	0.06	0.15	0.18	0.08	0.05	0.05	0.06	0.04	0.04	0.13	0.01	0.3
Current Ratio	2.08	1.76	1.74	1.93	1.86	1.9	1.67	1.72	1.7	1.59	1.73	1.47	1.11	1.09	0.58
Quick Ratio	0.88	0.69	0.68	0.71	0.7	0.77	0.66	0.56	0.52	0.58	0.55	0.53	0.44	0.13	0.4
CFO/Avg Current Liab	0.1	0.26	0.15	- -	0.27	0.18	0.05	0.08	0.12	0.25	0.09	0.22	0.43	0.09	-0.07
Common Equity/Total Assets	38.35	35.47	35.19	29.68	30.01	29.71	24.1	8.62	7.23	9.41	15.23	10.44	10.24	3.9	-37.81
Long-Term Debt/Equity (%)	23.14	22.12	20.76	61.42	57.27	58.81	88.7	317.87	351.72	155.32	118.25	285.37	228.64	321.96	- -
Long-Term Debt/Capital (%)	22.15	21.49	20.63	42.84	40.58	41.15	52.54	83.52	86.05	77.89	67.33	82.3	74.36	89.38	156.74
Long-Term Debt/Total Assets (%)	10.92	9.73	9.16	22.25	20.5	20.77	26.68	43.67	44.62	33.16	31.38	50.1	41.49	40.55	76.28
Total Debt/Equity (%)	23.14	22.12	20.76	61.42	57.27	58.81	88.7	317.87	351.72	155.32	118.25	287.26	251.03	329.27	-459.93
Total Debt/Capital (%)	22.15	21.49	20.63	42.84	40.58	41.15	52.54	83.52	86.05	77.89	67.33	82.84	81.64	91.4	177.69
Total Debt/Total Assets (%)	10.92	9.73	9.16	22.25	20.5	20.77	26.68	43.67	44.62	33.16	31.38	50.43	45.55	41.47	86.48
CFO/Total Liabilities	6.63	17.61	10.82	-0.22	15.17	10.68	2.4	3.55	5.22	12.93	4.78	7.32	17.77	3.97	-3.49
CFO/CapEx	1.88	5.61	2.34	-0.05	7.38	6.23	1.12	1.76	3.18	5.73	2.5	1.95	4.15	0.88	-0.51
Altman's Z-Score	7.68	6.83	6.84	6.27	6.34	6.38	5.06	3.81	3.75	4.27	5.14	3.92	1.51	1.26	1.43

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	17.64	16.99	16.34	15.75	16.1	16.29	13.65	12.43	12.87	12.33	14.16	13.78	3.75	6.56	17.58
Days Sales Outstanding	20.7	21.49	22.33	23.18	22.67	22.41	26.73	29.37	28.36	29.6	25.78	26.49	97.36	55.6	20.76
Inventory Turnover	10.18	10.12	10.36	10.06	9.44	9.19	8.55	7.37	6.68	6.05	6.06	5.75	1.09	2.38	20.74
Days Inventory Outstanding	35.85	36.07	35.23	36.28	38.67	39.7	42.71	49.49	54.64	60.33	60.22	63.52	333.99	153.61	17.6
Accounts Payable Turnover	14.19	13.4	12.77	13.36	13.08	11.65	9.68	8.58	8.49	8.06	8.53	7.41	0.96	0.47	4.09
Accounts Payable Turnover Days	25.73	27.23	28.58	27.31	27.91	31.33	37.7	42.56	42.98	45.29	42.81	49.24	380.44	783.71	89.24
Cash Conversion Cycle	30.82	30.33	28.98	32.15	33.42	30.78	31.74	36.31	40.03	44.65	43.19	40.78	50.91	-574.5	-50.88
Inventory to Cash Days	-15.16	-14.59	-12.89	-13.1	-15.99	-17.29	-15.98	-20.13	-26.28	-30.73	-34.44	-37.03	-236.63	-98.01	3.16
Inventories	806	764	772	872	941	916	990	1,274	1,146	1,234	1,496	1,334	1,111	68	74
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	76	78	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	62	59	- -
Finished Goods	806	764	772	872	941	916	990	1,274	1,146	1,234	1,496	1,334	1,052	68	74
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-72	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	1,744	1,789	2,290	2,185	2,235	2,156	1,133	380	313	1,714	3,164	1,455	1,460	1,003	215
- Cash & Cash Equivalents	136	98	102	57	161	185	105	66	67	83	56	69	243	28	282
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	1	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	213	215	213	609	568	565	901	1,648	1,625	1,106	1,110	2,716	2,320	1,931	2,120
Enterprise Value	1,822	1,908	2,402	2,736	2,642	2,535	1,929	1,961	1,872	2,737	4,218	4,102	3,537	2,906	2,054
Total Capital	960	1,002	1,032	1,420	1,401	1,372	1,714	1,973	1,889	1,420	1,648	3,279	2,842	2,112	1,193
Total Debt/Capital (%)	22.15	21.49	20.63	42.84	40.58	41.15	52.54	83.52	86.05	77.89	67.33	82.84	81.64	91.4	177.69
Total Debt / EV	0.12	0.11	0.09	0.22	0.22	0.22	0.47	0.84	0.87	0.4	0.26	0.66	0.66	0.66	1.03
EV/Sales	0.21	0.22	0.26	0.29	0.27	0.26	0.21	0.21	0.2	0.32	0.43	0.41	1.39	1.08	0.74
EV/EBITDA	7.26	7.74	9.2	10.3	8.97	9.06	9.21	8.81	8.51	8.17	7.91	8.12	8.31	7.66	4.71
EV/EBIT	8.41	9.22	11.41	13.52	11.55	11.3	12.86	16.25	18.14	11.32	9.54	14.82	16.42	14.67	9.26
EV/Cash Flow to Firm	23.83	8.43	16.18	472.69	9.22	12.38	19.88	10.83	7.69	6.74	25.93	6.95	4.37	10.53	333.4
EV/Free Cash Flow to Firm	16.16	7.19	11.52	35.72	8.18	10.79	13.06	7.95	6.33	5.88	19.86	5.42	3.58	6.34	9.9
Diluted Market Cap	1,749	1,792	2,291	2,185	2,235	2,156	1,133	380	313	1,718	3,284	1,489	1,460	1,003	215
Diluted Enterprise Value	1,827	1,910	2,403	2,737	2,642	2,535	1,929	1,961	1,872	2,741	4,338	4,135	3,537	2,906	2,054
EV per Share	29.03	30.4	38.35	43.98	42.54	41.5	32.15	32.68	30.9	43.19	57.99	55.06	46.68	37.87	26.7
TTM Sales	8,628	8,868	9,072	9,440	9,773	9,723	9,318	9,418	9,211	8,480	9,785	9,955	2,553	2,680	2,762
TTM EBITDA	251	247	261	266	295	280	209	223	220	335	533	505	426	379	436
TTM Operating Income	217	207	211	202	229	224	150	121	103	242	442	277	215	198	222
TTM Cash Flow to Firm	76	226	148	6	286	205	97	181	243	406	163	590	809	276	6
TTM Free Cash Flow to Firm	113	265	209	77	323	235	148	247	295	465	212	757	987	459	207

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	16.74	6.96	11.42	32.59	7.28	9.9	10.54	2.1	1.43	4.31	18.89	3.03	1.59	2.91	2.16
EV/EBIT	8.41	9.22	11.41	13.52	11.55	11.3	12.86	16.25	18.14	11.32	9.54	14.82	16.42	14.67	9.26
Enterprise Value	1,822	1,908	2,402	2,736	2,642	2,535	1,929	1,961	1,872	2,737	4,218	4,102	3,537	2,906	2,054
Low Price	25.87	26.97	28.62	31.55	31.89	30.43	17.75	5.83	2.43	3.63	23.58	14.1	11.79	11.42	2.38
EV/Sales	0.21	0.22	0.26	0.29	0.27	0.26	0.21	0.21	0.2	0.32	0.43	0.41	1.39	1.08	0.74
EV/EBITDA	7.26	7.74	9.2	10.3	8.97	9.06	9.21	8.81	8.51	8.17	7.91	8.12	8.31	7.66	4.71
Price/Earnings	15.14	16.42	20.65	33.15	21.81	20.03	15.56	- -	- -	57.38	14.28	64.98	- -	- -	- -
Price/Earnings Average	16.87	16.78	19.19	32.38	21.02	20.38	24.76	-2.11	-5	28.63	12.23	107.5	-32.85	-3.75	-0.48
Price/Earnings High	19.45	18.13	21.77	35.78	23.81	23.54	30.51	-3.15	-8.19	67.21	16.14	163.41	-43.41	-6	-1.09
Price/Earnings Low	14.09	15.53	16.16	29.79	19.33	17.27	14.63	-0.8	-2.36	7.7	7.74	46.92	-21.63	-2.42	-0.17
Price/Book Value	2.34	2.28	2.8	2.69	2.68	2.67	1.39	1.17	1.19	5.46	5.88	2.59	2.8	5.52	-0.23
Price/Book Value Average	2.6	2.33	2.6	2.63	2.59	2.72	2.22	2.83	1.18	2.72	5.03	4.28	2.6	7.49	-0.57
Price/Book Value High	3	2.52	2.95	2.9	2.93	3.14	2.73	4.23	1.94	6.39	6.64	6.5	3.44	11.98	-1.29
Price/Book Value Low	2.17	2.15	2.19	2.42	2.38	2.3	1.31	1.08	0.56	0.73	3.19	1.87	1.71	4.83	-0.2
Price/Tangible Book Value	2.69	2.73	3.23	4.76	4.68	4.66	9.67	-1.81	-1.45	22.97	9.35	-1.28	-1.36	-1.18	-0.12
Price/Tangible Book Value Average	3	2.79	3	4.65	4.51	4.74	15.38	-4.38	-1.44	11.46	8	-2.12	-1.26	-1.6	-0.29
Price/Tangible Book Value High	3.46	3.01	3.4	5.14	5.11	5.48	18.95	-6.55	-2.36	26.9	10.56	-3.22	-1.67	-2.55	-0.65
Price/Tangible Book Value Low	2.5	2.58	2.53	4.28	4.15	4.02	9.09	-1.67	-0.68	3.08	5.07	-0.92	-0.83	-1.03	-0.1
Price/Sales	0.2	0.2	0.25	0.23	0.23	0.22	0.12	0.04	0.03	0.2	0.32	0.15	0.57	0.37	0.08
Price/Sales Average	0.23	0.21	0.23	0.23	0.22	0.23	0.19	0.1	0.03	0.1	0.28	0.24	0.53	0.51	0.19
Price/Sales High	0.26	0.22	0.27	0.25	0.25	0.26	0.24	0.15	0.06	0.24	0.37	0.37	0.7	0.81	0.43
Price/Sales Low	0.19	0.19	0.2	0.21	0.2	0.19	0.11	0.04	0.02	0.03	0.18	0.11	0.35	0.33	0.07
Price/Cash Flow	25.59	8.19	16.29	-580.84	8.27	11.49	19.95	3.29	1.89	5.05	25.48	4.48	1.97	6.21	-2.12
Price/Cash Flow Average	28.51	8.37	15.14	-567.46	7.97	11.68	31.74	7.96	1.88	2.52	21.82	7.41	1.83	8.42	-5.22
Price/Cash Flow High	32.89	9.05	17.18	-627	9.03	13.5	39.12	11.89	3.07	5.92	28.8	11.26	2.42	13.47	-11.74
Price/Cash Flow Low	23.83	7.75	12.75	-521.95	7.33	9.9	18.76	3.03	0.89	0.68	13.81	3.23	1.21	5.43	-1.8
Price/Free Cash Flow Average	18.65	7.11	10.61	31.83	7.02	10.07	16.76	5.08	1.43	2.15	16.17	5.01	1.48	3.95	5.33
Price/Free Cash Flow High	21.51	7.69	12.04	35.17	7.95	11.63	20.66	7.58	2.34	5.05	21.34	7.61	1.95	6.32	12.01
Price/Free Cash Flow Low	15.58	6.58	8.94	29.28	6.46	8.54	9.91	1.93	0.67	0.58	10.24	2.19	0.97	2.55	1.84
EV/Sales Average	0.23	0.22	0.25	0.28	0.26	0.26	0.28	0.27	0.2	0.22	0.38	0.51	1.35	1.22	0.86
EV/Sales High	0.27	0.24	0.28	0.31	0.29	0.3	0.32	0.31	0.22	0.36	0.47	0.63	1.52	1.52	1.1
EV/Sales Low	0.2	0.2	0.21	0.27	0.24	0.23	0.2	0.21	0.19	0.15	0.28	0.37	1.16	1.04	0.73
EV/EBITDA Average	8.06	7.9	8.58	10.11	8.69	9.2	12.41	11.24	8.51	5.6	7.06	10	8.07	8.6	5.43
EV/EBITDA High	9.25	8.5	9.67	10.95	9.66	10.42	14.41	13.28	9.41	9.04	8.69	12.47	9.09	10.75	6.95
EV/EBITDA Low	6.78	7.35	7.29	9.46	8.1	8	8.89	8.68	7.76	3.74	5.2	7.31	6.98	7.33	4.63
EV/EBIT Average	9.33	9.41	10.64	13.27	11.2	11.47	17.33	20.73	18.13	7.77	8.51	18.26	15.94	16.48	10.68
EV/EBIT High	10.7	10.13	12	14.38	12.45	12.99	20.12	24.49	20.05	12.53	10.47	22.78	17.97	20.6	13.68
EV/EBIT Low	7.85	8.75	9.05	12.43	10.44	9.98	12.41	16	16.53	5.18	6.26	13.36	13.79	14.04	9.12
Last Price	27.79	28.51	36.56	35.11	35.98	35.29	18.88	6.33	5.17	27.05	43.5	19.53	19.27	13.07	2.8
High Price	35.71	31.49	38.55	37.9	39.29	41.48	37.02	22.91	8.43	31.68	49.16	49.11	23.66	28.35	15.54
Enterprise Value Average	2,021	1,948	2,239	2,686	2,562	2,572	2,598	2,502	1,871	1,878	3,764	5,054	3,434	3,264	2,369
Enterprise Value High	2,319	2,095	2,526	2,910	2,848	2,913	3,017	2,957	2,069	3,030	4,630	6,305	3,870	4,079	3,033
Enterprise Value Low	1,701	1,811	1,904	2,515	2,388	2,238	1,861	1,932	1,706	1,253	2,769	3,697	2,970	2,780	2,021

Shares Outstanding	63	63	63	63	63	61	61	62	63	73	75	76	77	77	76
Diluted Weighted Avg Shares	63	63	63	62	62	61	60	60	61	64	75	76	76	77	77
Basic Weighted Avg Shares	63	63	63	62	62	61	60	60	61	63	73	74	76	77	77
Revenue per Share	137.48	141.29	144.85	151.72	157.33	159.16	155.3	156.93	152.06	133.82	134.52	133.64	33.68	34.92	35.92
EBITDA per Share	4	3.93	4.17	4.27	4.75	4.58	3.49	3.71	3.63	5.29	7.33	6.78	5.62	4.94	5.67
Operating Income per Share	3.45	3.3	3.36	3.25	3.68	3.67	2.5	2.01	1.7	3.82	6.08	3.72	2.84	2.58	2.88
Basic EPS, GAAP	1.84	1.74	1.77	1.06	1.65	1.76	1.21	-7.28	-1.03	0.47	3.05	0.3	-0.54	-4.73	-14.31
Basic EPS from Cont Ops	1.84	1.74	1.77	1.07	1.66	1.78	1.21	-6.58	-0.37	1.39	3.05	0.3	0.12	-4.57	-1.34
Diluted EPS, GAAP	1.83	1.73	1.77	1.06	1.65	1.76	1.21	-7.28	-1.03	0.47	2.94	0.29	-0.54	-4.73	-14.31
Diluted EPS from Cont Ops	1.83	1.73	1.77	1.07	1.66	1.78	1.21	-6.58	-0.37	1.39	2.94	0.29	0.12	-4.57	-1.34
Dividend per Share	0.81	0.89	0.97	1.01	1.02	1.04	1.05	0.8	0.09	0.01	0.01	- -	- -	- -	- -
Cash Flow per Share	1.09	3.48	2.24	-0.06	4.35	3.07	0.95	1.93	2.74	5.35	1.71	4.36	9.77	2.1	-1.32
Free Cash Flow per Basic Share	0.51	2.86	1.28	-1.2	3.76	2.58	0.1	0.83	1.88	4.42	1.02	2.13	7.42	-0.28	-3.94
Cash & Equivalents per Share	2.17	1.56	1.63	0.91	2.59	3.04	1.74	1.1	1.11	1.31	0.77	0.93	3.21	0.36	3.67
Book Value per Share	11.9	12.52	13.06	13.05	13.4	13.22	13.56	5.42	4.35	4.95	7.4	7.55	6.89	2.37	-12.05
Tangible Book Value per Share	10.33	10.46	11.32	7.38	7.69	7.57	1.95	-3.5	-3.57	1.18	4.65	-15.25	-14.2	-11.1	-23.74

Accendra Health, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)